Episode 85
Biotech Hangout
00:00
Short Sellers vs. Biotech Companies
This chapter discusses the possibility of a company successfully suing a shortseller research house and the importance of having a decent auditor. The speakers also talk about the trend of biotech companies selling successful drugs and continuing to develop more medicines, as well as the strategy of spinouts and its benefits for management teams. They express optimism about the future of the biotech sector.
Transcript
Play full episode
